Additional analysis from precancerous ductal and lobular carcinoma in situ (DCIS and LCIS) breast tumors showed over one-third of these samples also harbored ESR1 amplifications suggesting that ESR1 amplifications present in early-stage breast cancer may drive disease progression. Here, ESR1 is linked to breast neoplasm.